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Ectopic pregnancy, a worldwide health problem, is potentially life-threatening and occurs in approximately 1.5–2% of all pregnancies in the
western world; however, the precise mechanisms underlying the initiation and development of tubal ectopic pregnancy are unknown. Tubal
abnormalities and dysfunction, such as altered contractility or abnormal ciliary activity, have been speculated to lead to tubal ectopic preg-
nancy. To elucidate the cellular and molecular mechanisms of the tubal transport process, several knockout (KO) mouse models have been
developed. This review summarizes what has been learned from studies of the Fallopian tube in caspase-1, cannabinoid receptor and Dicer1
KO mice. Our understanding of the mechanisms which contribute to tubal ectopic pregnancy in humans may be enhanced through further
study of these KO mouse models.
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Introduction
The aetiologies of many female reproductive tract diseases are
unknown. Approximately 21 of 1000 reported pregnancies and 1 of
1000 women between 15 and 44 years old are diagnosed with
ectopic pregnancy annually in the USA (Van Den Eeden et al.,
2005). However, throughout the western world ectopic pregnancy
is estimated to occur in approximately 1.5–2% of all pregnancies
(Barnhart, 2009). More than 95% of all ectopic pregnancies are
located in the Fallopian tube (Corpa, 2006). Women with tubal
ectopic pregnancy (tEP) not only have an increased rate of infertility,
but also have an increased risk for tEP in future pregnancies (Farquhar,
2005). Fallopian tube transport of the gamete and early embryo into
the uterus is crucial for the establishment of pregnancy in mammals
(Jansen, 1984). Abnormalities in the structure and function of the Fal-
lopian tube can interfere with the gamete/early embryo transport
process and lead to tEP (Farquhar, 2005); however, the molecular
mechanisms underlying this interference are not well characterized.
Although several related risk factors have been proposed, such as
pelvic infections, past or ever smoker and endometriosis (Farquhar,
2005; Corpa, 2006), the lack of appropriate animal models to study
tubal transport limits our understanding of the development of
human tEP at the cellular and molecular levels. This paper provides
an overview of current progress in our understanding of the molecular
mechanisms responsible for tubal dysfunction gained from studies of
genetically modiﬁed mice along side clinical studies, and a perspective
on the importance of integrating the phenotype analysis as a tool for
identifying and understanding the biological pathways in tubal
dysfunction.
Rodent models to study
Fallopian tube function
The mammalian Fallopian tube is a dynamic, steroid-responsive tissue
(Jansen, 1984). The hormone 17b-estradiol (E2) is implicated in the
regulation of cell proliferation, differentiation and apoptosis in the Fal-
lopian tube (Monroe et al., 2002). The key to the biological effects of
E2 is the activation of intracellular estrogen receptors (ER), which are
ligand-inducible transcription factors that regulate the expression of
many genes that control physiological processes (Dougherty and
Sanders, 2005). Withdrawal of E2 has been shown to induce cell
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(Monroe et al., 2002). Our preliminary results, obtained by western
blot and immunoﬂuorescence assay, indicate that caspase-1 is
expressed in human and mouse Fallopian tubes (unpublished data).
Since human and rodent Fallopian tube cells express both ERa and
ERb (Shao et al., 2007a, b; Horne et al., 2009), it would be predicted
that the transcriptional regulation of caspase-1 is ER-dependent in the
Fallopian tube in vivo; however, the primary function of caspase-1 is to
activate inﬂammatory cytokines rather than promote cell death in the
Fallopian tube. When compared with wild-type mice, female mice
with a targeted deletion of caspase-1 (Cheng et al., 2008) were less
susceptible to tubal inﬂammatory pathologies, such as the inﬂamma-
tory inﬁltration and hydrosalpinx formation by Chlamydia trachomatis
infection, one of the common risk factors for the induction of tEP in
humans (Farquhar, 2005; Barnhart, 2009). More recently, caspase-1
inhibitor (Z-YVAD-fmk, Biovision, Mountain View, CA, USA) has
been shown to suppress the growth and development of
C. trachomatis in infected cervical epithelial cells in vitro (Abdul-Sater
et al., 2009). Such an observation implies that the activation of
caspase-1 may result in the epithelial cells undergoing an inﬂammatory
process during chlamydial infection in vivo. Therefore, further investi-
gations to determine how the activation of endogenous caspase-1
affects the severity of the pathological tubal phenotype are warranted.
We have previously shown that the tubal transport of oocyte–
cumulus complex in superovulated immature mice is signiﬁcantly
enhanced or blocked in the presence of E2 or the ER antagonist ICI
182780, respectively, demonstrating effects on ER-mediated tubal
transport (Shao et al., 2009a). In agreement with the known role of
estrogen in regulating pro- or anti-inﬂammatory dynamics depending
on the tissue/cell type involved, we hypothesize that abrogated E2/
ER signalling and caspase-1-mediated inﬂammation in the Fallopian
tube possibly contribute to infection-induced tEP. We can also
expect that the use of caspase-1 knockout (KO) mice treated with
E2 and/or an inducer of inﬂammation will help us to elucidate novel
genes and pathways that play a functional role in the process of
tubal transport.
Endocannabinoids, a group of endogenous neuromodulatory lipids,
are known to activate two G protein-coupled cannabinoid receptors
CB1 and CB2 (Taylor et al., 2007), which are widely and differentially
expressed in many tissues and organs. It has been shown that only
CB1 is expressed in the Fallopian tube, and the levels of tubal CB1
in the follicular phase are lower than those in the luteal phase in
humans (Horne et al., 2008). Progesterone action, via binding to the
progesterone receptor, is involved in cellular function in the Fallopian
tube (Shao et al., 2006; Wa ˚nggren et al., 2008). Although the steroid
hormone regulation of tubal CB1 expression has not yet been
reported, elevated progesterone levels in the luteal phase have been
proposed as a regulator of Fallopian tube CB1 expression (Horne
et al., 2008). The biological importance of CB1 in the tubal transport
process is illustrated by the presence of retained embryos in mice that
lack either CB1 or CB1/2, or mice that have been treated with syn-
thetic CB1 antagonist (Wang et al., 2004). In contrast to CB1 and
CB1/2 KO mice, tubal transport is not affected in CB2 KO mice
(Wang et al., 2008): this difference in phenotype may reﬂect a differ-
ential distribution of CB receptors in the mouse Fallopian tube. More-
over, clinical validation of the close association between CB1
expression and human tEP comes from the fact that a decrease in
CB1 mRNA expression in the Fallopian tube is observed in women
with tEP (Horne et al., 2008). Previously, Paria et al. (1996) reported
that the Fallopian tubes of pregnant mice are capable of synthesizing
anandamide, a metabolic ligand for CB receptors. While smoking is
one of the risk factors for the development of tEP (Farquhar, 2005),
pre-clinical studies have shown that nicotine exposure results in
changes in endocannabinoid content in the brain (Le Foll et al.,
2008). Moreover, it has been speculated that an imbalance in endo-
cannabinoid levels in the circulation and reproductive tissues in
humans may be associated with an increased incidence of ectopic
pregnancy (Taylor et al., 2007). These observations, although
limited, provide compelling evidence that disturbances of endocanna-
binoid/CB1 signalling during tubal transport could result in the devel-
opment of tEP in humans. The success of future experiments to
identify the signiﬁcant loci of CB1 that predispose individuals to the
common form of human tEP will depend on the biological complexity
of this disorder (Horne et al., 2008). Interestingly, induction of inﬂam-
mation has been shown to inhibit CB1-mediated uterine contraction in
rats (Dmitrieva and Berkley, 2002). Therefore, it is tempting to
hypothesize that the inhibition of tubal CB1 signalling by the in vivo
action of cannabinoids may also contribute to inﬂammation-induced
tubal cell injury, and thus, inﬂuence tubal transport.
Dicer (encoded by Dicer1), a ribonuclease III enzyme required for
micro-RNA processing, has been demonstrated to play an essential
role in embryo implantation in mice and in the human endometrium
under pathophysiological conditions, such as endometriosis (Hong
et al., 2008). While the complete loss of Dicer1 in mice results in
early embryonic lethality (Bernstein et al., 2003), a considerable
number of studies in female mice carrying a ﬂoxed allele of Dicer1
under the control of antimu ¨llerian hormone receptor 2 promoter-
driven Cre recombinase has revealed that these mice exhibit tubal
hypotrophy with the formation of prominent tubal cysts, leading to
the disruption of tubal transport (Hong et al., 2008; Nagaraja et al.,
2008; Gonzalez and Behringer, 2009), which is likely a result of
abnormalities in the function of the uterotubal junction (Gonzalez
and Behringer, 2009). Moreover, disorganization of epithelial cells
and smooth muscle cells (Gonzalez and Behringer, 2009) was found
to correlate with alterations in the expression of tubal epithelial and
smooth muscle cell markers after the removal of Dicer (Nagaraja
et al., 2008); however, impaired ciliogenesis and ciliated function
were not observed in tissue-speciﬁc Dicer1 KO mouse Fallopian
tubes (Gonzalez and Behringer, 2009). To date, there are no pub-
lished reports regarding the expression and regulation of tubal
Dicer1 in humans during tubal transport and in tEP. A more conclusive
understanding of the precise mechanisms of how aberrant Dicer1
protein leads to human tEP will require further study; however, the
results discussed herein support the notion that the Dicer-mediated
integrity of normal tubal structure and function is necessary for tubal
transport. Although there is no difference in circulating E2 levels
between Dicer1 KO and wild-type mice (Hong et al., 2008; Gonzalez
and Behringer, 2009), it has recently been reported that E2 is able to
rapidly up-regulate Dicer1 gene expression through ERa activation
in luminal-type A/ERa-positive breast cancer cells in vitro
(Bhat-Nakshatri et al., 2009). The differences between the KO study
in vivo and the ER agonist results in vitro may be accounted for by
the differences in acute versus chronic effects of E2 in tissues/cells.
Thus, in the Fallopian tube, it cannot be completely ruled out that
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ing Dicer expression.
Summary and perspective
There is a gap in our knowledge about the precise reasons for and the
mechanisms underlying the implantation of an embryo in the Fallopian
tube (Farquhar, 2005). Fallopian tube function is regulated by complex
physiological and molecular processes, and therefore, the develop-
ment of genetically modiﬁed animal models provides a powerful
means to speciﬁcally investigate the impact of particular molecules
and their discreet pathways in tubal function, as well as pathologies
arising from the dysregulaion of these molecules. The deletion of
CB1 or Dicer1 in mice results in the retention of an oocyte/
embryo within the Fallopian tube and may provide clues for tubal
abnormality-induced tEP in humans. It is important to note that
while mice are genetically similar to humans and both share features
of tubal cell physiology, tEP is present in humans but is absent or
rare in rodents (Corpa, 2006). It is possible that the molecular mech-
anisms involved in tubal transport may be different in mice and
humans, thus, not all of the information gained from mouse models
may be applicable to human disease. The mammalian Fallopian tube
is composed of heterogeneous cell types: ciliated and secretory epi-
thelial cells as well as smooth muscle cells, all of which appear to be
specialized to perform different functions (Shao et al., 2007a, b).
Although the intricate manner by which numerous factors regulate
the process of tubal transport is clear, available studies indicate that
ciliary beating and smooth muscle activity are the major factors
responsible for propelling the gametes and embryo through the Fallo-
pian tube (Jansen, 1984). Mechanisms regulating ciliary beating and
smooth muscle activity are complex, and they can be either coordi-
nately or independently responsible for different stages of tubal trans-
port. In tubal cells, altered gene expression must presumably underlie
the process of tubal transport. Therefore, extensive studies of tem-
poral changes in the gene expression and in cell-speciﬁc signalling path-
ways in the Fallopian tube will be essential in order to understand the
contribution of each of these factors to tubal function. Genetically
modiﬁed mouse models could help us to elucidate the underlying mol-
ecular mechanisms that are responsible for ciliary beating and muscu-
lar activity in the Fallopian tube in vivo under physiological conditions
and in diseased states. A ﬁrst step would be to develop an in vitro
tubal cell/organ culture system in which gene programmes/pathways
could be manipulated and possibly scrutinized by microarray pro-
cedures. The net results of these future studies combined with infor-
mation from KO mouse models will add further important insight into
the biology of tubal transport processes. Moreover, the key issue
becomes one of whether CB1 or Dicer1 levels are regulated during
tubal transport under physiological conditions, thus, the contribution
of CB1 and Dicer1 to the process of tubal transport in wild-type
mice in vivo needs to be evaluated. Finally, experiments designed to
rescue CB1 or Dicer1 KO mice from the disruption of tubal transport
observed in these models are needed to test the role of potential
therapeutic targets. The coordination of oocyte/embryo–tubal epi-
thelial cell interaction plays a role in this process (Jansen, 1984), and
abnormalities in this interaction may also alter the timely homing of
the oocyte/embryo in the Fallopian tube (Shao et al., 2009b);
hence, a combination of different strategies and clinical studies
(Barnhart, 2009) is necessary to dissect the mechanisms underlying
tEP, still a poorly understood tubal disorder.
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